Tungsten West (OTC:TNGWF) Stock, Quote.Headers.trade-ideas

Tungsten West PLC owns and operates historical Hemerdon tungsten and tin mine located near Plymouth in southern Devon, England. It has a compliant Mineral Resource of approximately 325Mt at 0.12 per cent. WO3. The company's main country of operation is the United Kingdom.

Tungsten West PLC

Citigroup analyst Kyle Menges maintains United Rentals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URI#NYSE">URI</a>) with a Buy and raises the price target from $955 to $985.

News

Price Target

Analyst Ratings

Citigroup Maintains Buy on United Rentals, Raises Price Target to $985

Citigroup analyst Kyle Menges maintains PACCAR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>) with a Neutral and raises the price target from $120 to $125.

PCAR

Citigroup Maintains Neutral on PACCAR, Raises Price Target to $125

Citigroup analyst Kyle Menges maintains Deere (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>) with a Neutral and raises the price target from $460 to $470.

Citigroup Maintains Neutral on Deere, Raises Price Target to $470

Citigroup analyst Kyle Menges maintains Cummins (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>) with a Buy and raises the price target from $415 to $435.

Citigroup Maintains Buy on Cummins, Raises Price Target to $435

Citigroup analyst Kyle Menges maintains CNH Industrial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNH#NYSE">CNH</a>) with a Buy and raises the price target from $13 to $14.

Citigroup Maintains Buy on CNH Industrial, Raises Price Target to $14

In the current market session, Blue Bird Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBD#NASDAQ">BLBD</a>) share price is at $40.17, after a 0.27% spike. Moreover, over the past month, the stock decreased by 3.96%, but in the past year, increased by 62.17%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1733771709_0.png" alt="Past Year Chart" />

<h3>Evaluating Blue Bird P/E in Comparison to Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 15.87 in the Machinery industry, Blue Bird Inc. has a lower P/E ratio of 12.68. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1733771709_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

BLBD

P/E Ratio Insights for Blue Bird

GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) could provide a peek at holiday shopping demand when it reports third-quarter earnings <a href="https://www.benzinga.com/earnings">after market close Tuesday</a>.
Earnings Estimates: Analysts expect the video game to report third-quarter revenue of $887.7 million. That&#8217;s down from $1.08 billion in last year's third quarter, according to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120924&amp;t=be2bearmibe3na1">Benzinga Pro.</a>
The company reported revenue of $881.8 million and $798.3 million in this year's first and second quarters, respectively. GameStop has missed analyst estimates for revenue in four straight quarters and seven of the last 10 quarters.
Analysts expect the company to report a loss of 3 cents per share for the third quarter &#8212; down from breakeven earnings in last year's third quarter. The company reported a loss of 12 cents per share in the first quarter and a profit of 1 cent per share in the second quarter.
GameStop has beaten analyst estimates for earnings per share in five of the last 10 quarters.
Read Also: <a href="https://www.benzinga.com/general/gaming/24/11/42047265/gamestop-adds-nat-turner-to-board-does-the-move-show-bigger-bet-on-trading-cards-grading">GameStop Adds Nat Turner To Board: Does The Move Show Bigger Bet On Trading Cards, Grading?</a>
Key Items to Watch: GameStop provides minimal commentary in its earnings reports and has not held a conference call in several consecutive quarters.
Analysts and investors will be looking for indications from the company on how the quarter went, how the next quarter is shaping up and what the company will be doing with its cash going forward. Investors and analysts may not get all these answers on Tuesday.
GameStop <a href="https://www.benzinga.com/news/earnings/24/09/40803991/gamestop-q2-earnings-highlights-revenue-miss-eps-beat-cash-update-and-more">ended the second quarter </a>with $4.2 billion in cash, cash equivalents and marketable securities.
For months, investors have wondered what the company will do with the cash, whether it be acquisitions or new investment areas like trading cards and collectibles.
<h2 class="wp-block-heading">Will GameStop Buy Crypto?</h2>
Some investors believe the company should invest in Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>). So far, <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42196217/will-gamestop-amc-follow-microstrategy-rumble-into-bitcoin">other public companies</a> have purchased the leading cryptocurrency, including MicroStrategy and Tesla. 
GameStop <a href="https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36142175/meme-king-ryan-cohen-now-able-to-trade-stocks-with-gamestop-funds">quietly made a change</a> to how its cash was controlled in late 2023, giving power to CEO Ryan Cohen.
&#8220;On December 5, 2023, the Board of Directors approved a new investment policy that permits the Company to invest in equity securities, among other investments.&#8221;
GameStop went on to say that Cohen will direct the investment activity of the company in public and private markets. At times, GameStop and Cohen may be investing in the same companies, according to the filing.
The change allows Cohen to invest GameStop's cash into stocks and cryptocurrency without shareholder or Board approval, but he has yet to do so.
GameStop announcing it had bought Bitcoin would likely be one of the most talked about moments of the year for both the stock market and cryptocurrency sector, but right now it is just a wish for some.
Roaring Kitty, aka Keith Gill, recently tweeted for the<a href="https://www.benzinga.com/general/social-media/24/12/42349100/gamestop-rockets-as-roaring-kitty-returns-to-x-what-does-his-tweet-signal-ahead-of-q3-earnings"> first time since September</a>. The tweet caused GameStop stock to trade higher as he has often been linked to the company. The picture of a computer screen with a video playing at the 1:09 minute mark could point to Jan. 9 or something completely different.
While GameStop won't touch on anything related to Gill, the X account of Roaring Kitty will be closely monitored after the company's report to see if he has anything to say about the results.
In the second quarter, GameStop reported year-over-year declines across all three major business segments. Investors and analysts will be looking to see if the trend continues or if any growth is present.
Net sales by segment in the second quarter were as follows (comparable sales from last year&#8217;s second quarter in parentheses).
<ul>
<li>Hardware and Accessories: $451.2 million ($597.0 million)</li>
<li>Software: $207.7 million ($397.0 million)</li>
<li>Collectibles: $139.4 million ($169.8 million)</li>
</ul>
GameStop will likely not comment on the fourth quarter, which includes the holiday shopping season. Still, investors and analysts are hoping for some color.
Wedbush analyst Michael Pachter said GameStop <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40816734/gamestop-analyst-says-retailer-could-close-all-stores-operate-as-bank-to-manage-los">provided no strategy</a> for its future as it trades at a premium to its cash after the second-quarter earnings report. Pachter reiterated an Underperform rating and lowered the price target from $11 to $10 at the time.
&#8220;Without a hint of any strategy that would reasonably deploy capital, we do not see why shares trade at 2x cash," Pachter said.
The video game retailer announced accelerated store closures, but without more commentary on strategy, Pachter said the company is &#8220;no longer beholden to shareholder interests.&#8221;
Pachter said the store closures will result in further revenue declines and could also hurt profitability.
&#8220;Without any indication that the company plans a turnaround, we remain reluctant to assume that it can and will. Instead, it appears to be moving further away from any shareholder accountability.&#8221;
Price Action: GameStop stock is down 0.21% to $29.00 at last check on Monday. Its 52-week trading range is $9.95 to $64.83. GameStop stock is up 77% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/gaming/24/12/42363002/gamestop-ahead-of-q3-earnings-will-meme-magic-last-or-metrics-rule">GameStop Ahead Of Q3 Earnings: Will Meme Magic Last Or Metrics Rule?</a></li>
</ul>
Image: Shutterstock

Gaming

Trading Ideas

$BTC

GameStop Q3 Earnings Preview: Investors Want Bitcoin On Balance Sheet, Analyst Wants 'Hint Of Any Strategy'

Citigroup analyst Kyle Menges maintains Caterpillar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>) with a Buy and raises the price target from $435 to $460.

Citigroup Maintains Buy on Caterpillar, Raises Price Target to $460

Citigroup analyst Kyle Menges maintains Allison Transmission (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALSN#NYSE">ALSN</a>) with a Neutral and raises the price target from $125 to $130.

ALSN

Citigroup Maintains Neutral on Allison Transmission, Raises Price Target to $130

In President Joe Biden's waning days at the White House, he&#8217;s facing <a href="http://24/11/42202403/elizabeth-warren-bernie-sanders-12-congress-members-to-biden-issue-clemency-and-pardons-for-cannabis-prisoners">increasing pressure</a> to act on his promise to pardon cannabis prisoners, especially after his widely criticized <a href="https://www.benzinga.com/24/12/42258387/biden-grants-full-and-unconditional-pardon-to-hunter-i-hope-americans-will-understand">pardon of his son</a> Hunter Biden.
White House Press Secretary <a href="https://www.benzinga.com/topic/karine-jean-pierre">Karine Jean-Pierre</a> was asked in a press briefing on Dec. 6 if the president is considering &#8220;blanket pardons&#8221; for government officials who are being targeted by President-elect Donald Trump as <a href="https://www.benzinga.com/news/23/11/35614093/donald-trump-reportedly-outlined-plan-for-punitive-actions-against-critics-in-potential-second-term">perceived enemies</a> in order to protect them from retribution, as was previously <a href="https://www.nytimes.com/2024/12/05/us/politics/biden-trump-pardons.html?smid=nytcore-ios-share&amp;referringSource=articleShare">reported</a> by the NY Times. While Trump&#8217;s list of enemies does not (thankfully) include cannabis prisoners, Jean-Pierre said the president is reviewing next steps and "there will be more to come."
"I&#8217;m not going to get ahead of the president. But what I can say is that the president is reviewing other pardons and commutations," she <a href="https://rollcall.com/factbase/biden/transcript/joe-biden-press-conference-briefing-karine-jean-pierre-december-6-2024/">said</a> at the press briefing. "I hope folks don't forget what the president has been able to do — the actions that he's been able to take over the last four years."
It&#8217;s been over two years since&nbsp;<a href="https://www.benzinga.com/markets/cannabis/22/10/29175510/breaking-biden-announces-pardons-for-all-federal-marijuana-possession-convictions">Biden announced</a> he would pardon all prior federal offenses&nbsp;of simple<a href="https://www.benzinga.com/markets/cannabis/22/10/29175510/breaking-biden-announces-pardons-for-all-federal-marijuana-possession-convictions" target="_blank" rel="noreferrer noopener"> </a>marijuana possession. Since then, not one single person among the approximately 3,000 people has been released. This fact is starting to irk advocates, prisoners' families and we can only assume those still sitting in prison.
Read Also: <a href="https://www.benzinga.com/24/12/42373720/deas-cannabis-rescheduling-hearing-set-to-begin-in-january-2025-as-controversy-mounts">DEA&#8217;s Cannabis Rescheduling Hearing Set To Begin In January 2025 As Controversy Mounts</a>
<h1 class="wp-block-heading">Why Is This So Difficult?</h1>
Further pressed by reporters to spill the plans on what the Biden administration intends to do on this touchy topic of pardons and commutations, Jean-Pierre listed the president&#8217;s accomplishments.
"He&#8217;s issued more sentence commutations at this point in his presidency than any of his recent predecessors at the same point in their first terms," Jean-Pierre said. "This is in addition to groundbreaking categorical pardons that the president issued to address marijuana possession convictions, military convictions and the LGBTQI+ community."
Meanwhile, internal pressure grows. In a late November <a href="https://www.benzinga.com/news/legal/24/11/42202403/elizabeth-warren-bernie-sanders-12-congress-members-to-biden-issue-clemency-and-pardons-for-cannabis-prisoners">letter</a> addressed to Biden and Vice President Kamala Harris, Sens. Elizabeth Warren (D-Mass.), Barbara Lee (D-Calif.), Bernie Sanders (I-VT.) as well as Reps. Earl Blumenauer (D-Ore.) and Ilhan Omar (D-Minn.) along with nine more colleagues urged them to expand the president&#8217;s marijuana pardons and deprioritize federal cannabis prosecutions before the end of the Biden&#8217;s term in the White House.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/news/global/24/12/42394186/war-on-drugs-has-failed-completely-and-utterly-un-high-commissioner-urges-evidence-based-solutions">War On Drugs &#8216;Has Failed, Completely And Utterly&#8217;: UN High Commissioner Urges Evidence-Based Solutions</a></li>
</ul>
Photo: Benzinga edit of images by Wikimedia Commons and&nbsp;<a href="https://unsplash.com/@2hmedia?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText" target="_blank" rel="noreferrer noopener">2H Media</a>&nbsp;on&nbsp;<a href="https://unsplash.com/photos/1SDw4biQ6us?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText" target="_blank" rel="noreferrer noopener">Unsplash</a>

Cannabis

Government

Politics

Legal

Biden Considers Blanket Pardons Amid Trump Retribution Threats: Will Cannabis Prisoners Benefit?

Citigroup analyst Kyle Menges maintains AGCO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGCO#NYSE">AGCO</a>) with a Neutral and raises the price target from $95 to $100.

AGCO

Citigroup Maintains Neutral on AGCO, Raises Price Target to $100

Marvel Rivals has drawn an impressive 10 million players across platforms in <a href="https://www.benzinga.com/general/gaming">its first weekend. </a>
The free-to-play six-on-six team shooter from NetEase Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTES#NASDAQ">NTES</a>) launched last Friday on PC via Steam and the Epic Games Store, as well as PlayStation 5 and Xbox Series X/S.
See Also:<a href="https://www.benzinga.com/24/12/42366954/neteases-marvel-rivals-launches-with-444000-players-on-steam"> NetEase&#8217;s Marvel Rivals Launches With 444,000 Players On Steam</a>
NetEase announced the milestone at midnight, confirming the game's strong start as players worldwide joined the action-packed battles featuring Marvel's iconic characters.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f389; In just 72 hours, we've reached an incredible milestone of 10 million players worldwide! &#x1f389; We want to extend our heartfelt thanks to each and every one of you. &#x1faf6; Let's ignite the battle together! &#x1f496;<a href="https://twitter.com/hashtag/MarvelRivals?src=hash&amp;ref_src=twsrc%5Etfw">#MarvelRivals</a> <a href="https://t.co/5njTulx24e">pic.twitter.com/5njTulx24e</a>
&mdash; Marvel Rivals (@MarvelRivals) <a href="https://twitter.com/MarvelRivals/status/1865909229070016851?ref_src=twsrc%5Etfw">December 9, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<h3 class="wp-block-heading">Fan-Favorite Heroes Take Center Stage</h3>
The game's roster includes popular Marvel Cinematic Universe (MCU) heroes like Iron Man, Hulk, and Scarlet Witch, along with comic-book favorites such as Cloak and Dagger, Iron Fist, and Squirrel Girl. Players have praised the mix of well-known characters and lesser-seen heroes, with many hoping Squirrel Girl might finally get her MCU debut.
Marvel Rivals' gameplay has been compared to Blizzard's Overwatch, now owned by Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), due to its team-based structure and character-specific abilities. Fans have noted the similarities, though many have also welcomed the new take on the hero shooter format.
<h3 class="wp-block-heading">Controversy Over Character Design</h3>
Former Blizzard president Mike Ybarra sparked debate over the weekend by calling Marvel Rivals an &#8220;Overwatch copycat.&#8221; 
He also suggested the design of Black Widow—a character created in 1964 by Marvel legend Stan Lee—bore similarities to Overwatch's sniper hero, Widowmaker. Fans quickly responded, defending Marvel's decades-long legacy.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42371743/sony-worried-when-xbox-arrived-gta-playstation-turn-the-console-wars">Sony &#8216;Worried&#8217; When Xbox Arrived, But GTA Gave PlayStation An Edge</a></li>
</ul>
Photo: Shutterstock

General

MSFT

NTES

Marvel Rivals Stuns With 10 Million Players In First Weekend

Citigroup analyst Andrew Kaplowitz upgrades Xylem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYL#NYSE">XYL</a>) from Neutral to Buy and raises the price target from $135 to $148.

Upgrades

Citigroup Upgrades Xylem to Buy, Raises Price Target to $148

Citigroup analyst Andrew Kaplowitz downgrades Fortive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTV#NYSE">FTV</a>) from Buy to Neutral and lowers the price target from $92 to $86.

Downgrades

Citigroup Downgrades Fortive to Neutral, Lowers Price Target to $86

Disney CFO Says 'It'll Be A Shame' If Sports Joint Venture Service Venu Fails To Launch

OneMain Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMF#NYSE">OMF</a>) has been analyzed by 13 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">9</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated OneMain Holdings and provided 12-month price targets. The average target is $56.54, accompanied by a high estimate of $63.00 and a low estimate of $46.00. Highlighting a 0.81% decrease, the current average has fallen from the previous average price target of $57.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1733770868_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The analysis of recent analyst actions sheds light on the perception of OneMain Holdings by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Richard Shane</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$59.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Kyle Joseph</td>
<td>Stephens &amp; Co.</td>
<td>Announces</td>
<td>Overweight</td>
<td>$57.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Kaye</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$52.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>David Scharf</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$62.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Giuliano Bologna</td>
<td>Compass Point</td>
<td>Raises</td>
<td>Buy</td>
<td>$63.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Kenneth Lee</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$58.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>David Scharf</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$60.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Michael Kaye</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$49.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Kenneth Lee</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$58.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Terry Ma</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$46.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Richard Shane</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$51.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>David Scharf</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$60.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Kenneth Lee</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$60.00</td>
<td>$60.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to OneMain Holdings. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of OneMain Holdings compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into OneMain Holdings's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/OMF/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on OneMain Holdings analyst ratings.</a>
<h2>About OneMain Holdings</h2>
OneMain Holdings Inc is engaged in nonprime consumer finance companies in the United States and is one of only a few companies in the consumer installment lending industry. It formed after a transaction brought together two branch-based consumer finance companies with complementary strategies and locations. Its services include providing personal loan products, offering credit and noncredit insurance, servicing loans, pursuing strategic acquisitions and dispositions of assets and businesses, and on occasion, establishing joint ventures or forming strategic alliances. The company's one reportable segment is consumer and insurance. In addition to hundreds of branches, the company also has an online business. The main source of revenue is net interest income.
<h3>Understanding the Numbers: OneMain Holdings's Finances</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, OneMain Holdings showcased positive performance, achieving a revenue growth rate of 7.28% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: OneMain Holdings's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 13.49%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): OneMain Holdings's ROE stands out, surpassing industry averages. With an impressive ROE of 4.94%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): OneMain Holdings's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.62%, the company may face hurdles in achieving optimal financial performance.
Debt Management: OneMain Holdings's debt-to-equity ratio is notably higher than the industry average. With a ratio of 6.59, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Basics of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Scoreboard: 13 Ratings For OneMain Holdings

DexCom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for DexCom, presenting an average target of $98.44, a high estimate of $120.00, and a low estimate of $85.00. Highlighting a 1.12% decrease, the current average has fallen from the previous average price target of $99.56. 
<img src="https://www.benzinga.com/files/images/story/2024/1733770860_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The perception of DexCom by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>William Plovanic</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$99.00</td>
<td>$89.00</td>
</tr>
<tr>
<td>Lee Hambright</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Outperform</td>
<td>$86.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Jayson Bedford</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Strong Buy</td>
<td>$99.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Shagun Singh</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$115.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Steven Lichtman</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$105.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Robbie Marcus</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$85.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Mike Kratky</td>
<td>Leerink Partners</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$87.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Larry Biegelsen</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$90.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Shagun Singh</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$120.00</td>
<td>$130.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to DexCom. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of DexCom compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of DexCom's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of DexCom's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/DXCM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on DexCom analyst ratings.</a>
<h2>All You Need to Know About DexCom</h2>
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
<h3>A Deep Dive into DexCom's Financials</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: DexCom's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 1.97%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: DexCom's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 13.54%, the company may face hurdles in effective cost management.
Return on Equity (ROE): DexCom's ROE excels beyond industry benchmarks, reaching 6.1%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): DexCom's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 2.05%, the company may face hurdles in achieving optimal financial performance.
Debt Management: DexCom's debt-to-equity ratio stands notably higher than the industry average, reaching 1.31. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DXCM

Key Takeaways From DexCom Analyst Ratings

In the last three months, 7 analysts have published ratings on Alkami Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALKT#NASDAQ">ALKT</a>), offering a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $44.43, a high estimate of $54.00, and a low estimate of $39.00. Surpassing the previous average price target of $38.71, the current average has increased by 14.78%.
<img src="https://www.benzinga.com/files/images/story/2024/1733770853_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The perception of Alkami Technology by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alexei Gogolev</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$45.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Adam Hotchkiss</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$39.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Patrick Walravens</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$46.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Saket Kalia</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$41.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Jeff Van Rhee</td>
<td>Craig-Hallum</td>
<td>Raises</td>
<td>Buy</td>
<td>$45.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$54.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Patrick Walravens</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$41.00</td>
<td>$38.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Alkami Technology. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Alkami Technology compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Alkami Technology's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Alkami Technology's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/ALKT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Alkami Technology analyst ratings.</a>
<h2>All You Need to Know About Alkami Technology</h2>
Alkami Technology Inc is a cloud-based digital banking solutions provider. Alkami Platform, allows FIs to onboard and engage new users, accelerate revenues and meaningfully improve operational efficiency with the support of a proprietary, true cloud-based, multi-tenant architecture.
<h3>Alkami Technology's Financial Performance</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Alkami Technology displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 26.89%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -10.99%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -2.84%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Alkami Technology's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -2.29%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.06, Alkami Technology adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>How Are Analyst Ratings Determined?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALKT

Alkami Technology Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)

Across the recent three months, 10 analysts have shared their insights on Paycom Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAYC#NYSE">PAYC</a>), expressing a variety of opinions spanning from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">10</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $190.8, along with a high estimate of $248.00 and a low estimate of $170.00. Marking an increase of 11.38%, the current average surpasses the previous average price target of $171.30. 
<img src="https://www.benzinga.com/files/images/story/2024/1733770845_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Paycom Software. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jared Levine</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Hold</td>
<td>$248.00</td>
<td>$193.00</td>
</tr>
<tr>
<td>Siti Panigrahi</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$190.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Steven Enders</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$196.00</td>
<td>$172.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$181.00</td>
<td>$172.00</td>
</tr>
<tr>
<td>Samad Samana</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$175.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Daniel Jester</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$197.00</td>
<td>$183.00</td>
</tr>
<tr>
<td>Arvind Ramnani</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$191.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Samad Samana</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$170.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$172.00</td>
<td>$167.00</td>
</tr>
<tr>
<td>Jared Levine</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Hold</td>
<td>$188.00</td>
<td>$171.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Paycom Software. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Paycom Software compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Paycom Software's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PAYC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Paycom Software analyst ratings.</a>
<h2>About Paycom Software</h2>
Paycom is a fast-growing provider of payroll and human capital management software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 19,500 clients as of 2023, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
<h3>A Deep Dive into Paycom Software's Financials</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Paycom Software's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 11.23%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Industrials sector.
Net Margin: Paycom Software's net margin excels beyond industry benchmarks, reaching 16.21%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Paycom Software's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.07% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Paycom Software's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.88%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.06.
<h2>The Basics of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PAYC

Decoding 10 Analyst Evaluations For Paycom Software

Barclays analyst Seth Sigman maintains Tractor Supply (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSCO#NASDAQ">TSCO</a>) with a Equal-Weight and raises the price target from $250 to $262.

Comments

Tungsten West

Tungsten West (TNGWF) Forecast

Tungsten West (OTC:TNGWF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga